Bio-Techne Corp $TECH Shares Sold by BNP PARIBAS ASSET MANAGEMENT Holding S.A.

Impact · against what's priced in

The near-total divestment of Bio-Techne Corp by BNP Paribas Asset Management suggests a significant institutional shift in sentiment. While 13F filings are lagging indicators, a 95.8% position reduction by a major holder is a negative signal for institutional demand.

TECH−0.20

No priced-in read yet

In context

BNP Paribas Asset Management sold 59,110 shares, reducing its position by 95.8%, which indicates a loss of conviction from a major institutional investor.

Read from the article alone

• biotechnology▲43%
• 13f
• TECH
• institutional ownership
• portfolio reduction

Top 1 mover · tap to explore